Last update :
19/11/2024
Anticoagulant   Dalteparin sodium  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Dalpin India
Daltehep India
Daltepin India
Fragmin Australia, Austria, Belgium, Canada, Chile, Colombia, Denmark, Ecuador, Egypt, Finland, Germany, Great Britain, Greece, Hungary, Iceland, India, Iran, Italy, Malaysia, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland, Tunisia, Turkey, United Arab Emirates, United States of America, Venezuela
Fragmine France
Stability in solutions   injection   Stability in solutions : Dalteparin sodium     
Container Solvent Concentration Temperature Storage Duration of stability References
Polypropylene Not specified 10000 UI/ml 2-5°C Protect from light
15 Day
1624
Biological analysis

Polypropylene Not specified 10000 UI/ml 25°C Light
10 Day
1624
Biological analysis

Polypropylen Syringe Sodium chloride 0,9% 1000 UI/ml 2-8°C Light
30 Day
4031
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 2500 UI/ml 4°C Not specified
28 Day
2268
Level of evidence C

Polypropylen Syringe None 10000 UI/ml 25°C Not specified
30 Day
1873

Polypropylen Syringe None 25000 UI/ml 4°C Not specified
30 Day
1873


  Mentions Légales